PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: RADIATION: PET Imaging With Cu-64 Labeled Trastuzumab|RADIATION: PET Imaging With Cu-64 Labeled Trastuzumab
Sponsor: Memorial Sloan Kettering Cancer Center